Journal
CURRENT DIABETES REPORTS
Volume 14, Issue 11, Pages -Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11892-014-0548-3
Keywords
Diabetes; Fasting glucose; Hemoglobin A1c; Fructosamine; Glycated albumin; 1,5-Anhydroglucitol; Hyperglycemia; Biomarkers
Categories
Funding
- NIH/NHLBI [T32HL007024]
- NIH/NIDDK [R01DK089174]
Ask authors/readers for more resources
Fasting glucose and hemoglobin A1c (HbA1c) are the standard measures for diagnosis and monitoring of diabetes. There has been recent interest in nontraditional markers of hyperglycemia, including fructosamine, glycated albumin, and 1,5-anhydroglucitol (1,5-AG), as alternatives or adjuncts to standard measures. There is a growing literature linking these nontraditional markers with microvascular and macrovascular complications. Fructosamine and glycated albumin have also been shown to improve identification of persons with diabetes. However, long-term prospective studies with clinical outcomes are lacking. Some modern laboratory assays for fructosamine, glycated albumin, and 1,5-AG have excellent performance. Expanded use of these tests has the potential to improve diabetes care as these measures may overcome limitations of HbA1c in certain patients, complement traditional measures by providing additional information on shorter-term glycemic control, and improve risk stratification for diabetes and its complications. Nonetheless, studies are needed to demonstrate if their routine use will benefit patients and improve outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available